导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.10% | 1628/4773 |
| 近一周 | -1.08% | 2779/5462 |
| 近一月 | -3.80% | 3160/5421 |
| 近一季 | -9.13% | 3229/5209 |
| 近半年 | -4.95% | 3173/4920 |
| 近一年 | 8.41% | 1296/4366 |
| 近两年 | 76.18% | 906/2954 |
| 近三年 | 39.17% | 799/2253 |
| 成立以来 | 71.39% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.94% 1125/4961 |
19.39% 1299/5312 |
- - |
- - |
| 2025 | 31.88% 1210/4813 |
2.18% 1445/3635 |
1.85% 2085/4076 |
25.44% 1399/4524 |
1.02% 1588/4813 |
| 2024 | 6.81% 1720/3463 |
-2.77% 1429/2808 |
-5.34% 1695/3014 |
16.45% 1452/3129 |
-0.34% 1390/3463 |
| 2023 | -6.62% 863/2656 |
7.88% 517/2280 |
-4.35% 1144/2385 |
-4.88% 1245/2515 |
-4.86% 1197/2655 |
| 2022 | -18.85% 766/2207 |
-14.12% 907/1919 |
3.14% 1208/2016 |
-10.93% 470/2113 |
2.85% 816/2208 |
| 2021 | 15.73% 297/1822 |
-1.76% 539/1255 |
9.23% 578/1330 |
4.34% 362/1466 |
3.36% 447/1822 |
| 2020 | - - |
- - |
- - |
11.86% 422/1164 |
3.33% 922/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 中银证券中证500ETF VS. 长安沪深300非周期A(740101) |